Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)

Nahum Méndez-Sánchez; Miguel Dibildox-Martinez; Jahir Sosa-Noguera; Ramón Sánchez-Medal; Francisco J. Flores-Murrieta

doi:10.1186/s40360-021-00500-2

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)

Nahum Méndez-Sánchez, Miguel Dibildox-Martinez, Jahir Sosa-Noguera, Ramón Sánchez-Medal, Francisco J. Flores-Murrieta

Escuela Superior de Medicina (ESM)

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1. The incorrect sentence is: SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The correct sentence is: SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The original article has been corrected.

Original language	English
Article number	37
Journal	BMC Pharmacology and Toxicology
Volume	22
Issue number	1
DOIs	https://doi.org/10.1186/s40360-021-00500-2
State	Published - Dec 2021

Access to Document

10.1186/s40360-021-00500-2

Fingerprint

Dive into the research topics of 'Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)'. Together they form a unique fingerprint.

Cite this

Méndez-Sánchez, N., Dibildox-Martinez, M., Sosa-Noguera, J., Sánchez-Medal, R., & Flores-Murrieta, F. J. (2021). Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8). BMC Pharmacology and Toxicology, 22(1), Article 37. https://doi.org/10.1186/s40360-021-00500-2

Méndez-Sánchez, Nahum ; Dibildox-Martinez, Miguel ; Sosa-Noguera, Jahir et al. / Correction to : Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8). In: BMC Pharmacology and Toxicology. 2021 ; Vol. 22, No. 1.

@article{4282aa25c65c4dd8a5a3ff5685376990,

title = "Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)",

abstract = "After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1. The incorrect sentence is: SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The correct sentence is: SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The original article has been corrected.",

author = "Nahum M{\'e}ndez-S{\'a}nchez and Miguel Dibildox-Martinez and Jahir Sosa-Noguera and Ram{\'o}n S{\'a}nchez-Medal and Flores-Murrieta, {Francisco J.}",

note = "Publisher Copyright: {\textcopyright} The Author(s). 2021",

year = "2021",

month = dec,

doi = "10.1186/s40360-021-00500-2",

language = "Ingl{\'e}s",

volume = "22",

journal = "BMC Pharmacology and Toxicology",

issn = "2050-6511",

number = "1",

}

Méndez-Sánchez, N, Dibildox-Martinez, M, Sosa-Noguera, J, Sánchez-Medal, R & Flores-Murrieta, FJ 2021, 'Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)', BMC Pharmacology and Toxicology, vol. 22, no. 1, 37. https://doi.org/10.1186/s40360-021-00500-2

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8). / Méndez-Sánchez, Nahum; Dibildox-Martinez, Miguel; Sosa-Noguera, Jahir et al.
In: BMC Pharmacology and Toxicology, Vol. 22, No. 1, 37, 12.2021.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)

AU - Méndez-Sánchez, Nahum

AU - Dibildox-Martinez, Miguel

AU - Sosa-Noguera, Jahir

AU - Sánchez-Medal, Ramón

AU - Flores-Murrieta, Francisco J.

PY - 2021/12

Y1 - 2021/12

N2 - After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1. The incorrect sentence is: SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The correct sentence is: SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The original article has been corrected.

AB - After publication of the original article [1], an error was identified in the Results section, with regard to values of Table 1. The incorrect sentence is: SIB peak plasma concentrations were 207.1 mg/L for SPC and 12.6 mg/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The correct sentence is: SIB peak plasma concentrations were 207.1 ng/L for SPC and 12.6 ng/L for SM tablets. All pharmacokinetic parameters differed significantly between formulations (P < 0.0001). The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85108895912&partnerID=8YFLogxK

U2 - 10.1186/s40360-021-00500-2

DO - 10.1186/s40360-021-00500-2

M3 - Comentario/Debate

C2 - 34172076

AN - SCOPUS:85108895912

SN - 2050-6511

VL - 22

JO - BMC Pharmacology and Toxicology

JF - BMC Pharmacology and Toxicology

IS - 1

M1 - 37

ER -

Méndez-Sánchez N, Dibildox-Martinez M, Sosa-Noguera J, Sánchez-Medal R, Flores-Murrieta FJ. Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8). BMC Pharmacology and Toxicology. 2021 Dec;22(1):37. doi: 10.1186/s40360-021-00500-2

Correction to: Superior silybin bioavailability of silybin–phosphatidylcholine complex in oily-medium soft-gel capsules versus conventional silymarin tablets in healthy volunteers* (BMC Pharmacology and Toxicology, (2019), 20, 1, (5), 10.1186/s40360-018-0280-8)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this